ArticleInvestigational new drugs2022

Phase I study of lurbinectedin in combination with weekly paclitaxel with or without bevacizumab in patients with advanced solid tumors.

Emiliano Calvo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.